Table: RaQualia Pharma -2025 parent results

RaQualia Pharma

13/02/2026 06:42

Feb 13 (Reuters)- 
          RaQualia Pharma Inc 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to     NEXT     
                Dec 31, 2025    Dec 31, 2024   Dec 31, 2026     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales             2.90            2.50                                 
                 (+16.3 pct)     (+52.0 pct)                             
  Operating        690 mln         322 mln                               
                (+114.1 pct)                                             
  Recurring        661 mln         196 mln                               
                (+236.3 pct)                                             
  Net              498 mln         56 mln                                
                (+787.5 pct)                                             
  EPS             21.06 yen       2.60 yen                               
  EPS Diluted     20.74 yen       2.60 yen                               
  Ann Div            NIL             NIL            NIL                  
  -Q2 Div            NIL             NIL            NIL                  
  -Q4 Div            NIL             NIL            NIL                  
  
  NOTE - RaQualia Pharma Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4579.T